Search Results - "Backer, T."

Gender gap in risk factor control of coronary patients far from closing: results from the European Society of Cardiology EUROASPIRE V registry by Vynckier, Pieter, Ferrannini, Giulia, Rydén, Lars, Jankowski, Piotr, De Backer, Tine, Gevaert, Sofie, De Bacquer, Dirk, De Smedt, Delphine

“…This study aims to provide an overview on contemporary gender differences in the risk factor control of coronary heart disease (CHD) patients. Analyses were…”
Get full text

Preemptive Analgesia Decreases Pain Following Anorectal Surgery: A Prospective, Randomized, Double-Blinded, Placebo-Controlled Trial by Van Backer, Justin T, Jordan, Matthew R, Leahy, Danielle T, Moore, Jesse S, Callas, Peter, Dominick, Timothy, Cataldo, Peter A

“…BACKGROUND:Postoperative pain is a frequent cause for delayed discharge following outpatient procedures, including anorectal surgery. Both central and…”
Get full text

MANAGEMENT OF UNCONTROLLED TREATED HYPERTENSION IN PRIMARY CARE IN BELGIUM AND LUXEMBOURG by de Backer, T, van Nieuwenhuyse, B, de Bacquer, D

“…OBJECTIVE:Despite effective treatments, blood pressure (BP) control remains low. This study identifies key drivers of therapeutic inertia in Belgium and…”
Get full text

Medical Treatment in Coronary Patients: Is there Still a Gender Gap? Results from European Society of Cardiology EUROASPIRE V Registry by Vynckier, Pieter, Ferrannini, Giulia, Rydén, Lars, Tokgözoğlu, Lale, Bruthans, Jan, Kotseva, Kornelia, Wood, David, De Backer, Tine, Gevaert, Sofie, De Bacquer, Dirk, De Smedt, Delphine

“…Purpose This study is aimed at investigating gender differences in the medical management of patients with coronary heart disease (CHD). Methods Analyses were…”
Get full text

Reciprocity in autistic and typically developing children and adolescents with and without mild intellectual disabilities by Backer van Ommeren, T., Koot, H. M., Begeer, S.

“…The assessment of autism in individuals with mild intellectual disabilities (MID) is complicated because of the overlap between autistic traits and…”
Get full text

Covid-19 associated reduction in hypertension-related diagnostic and therapeutic procedures in Excellence Centers of the European Society of Hypertension by Weber, Thomas, Amar, Jaques, de Backer, Tine, Burkard, Thilo, van der Giet, Marcus, Gosse, Philippe, Januszewicz, Andrzej, Kahan, Thomas, Mancia, Giuseppe, Mayer, Christopher C., Muiesan, Maria Lorenza, Stergiou, George S., Tsioufis, Konstantinos, Vaisse, Bernard, Kreutz, Reinhold

“…The Covid-19 pandemic necessitated a decrease in non-Covid-19 related diagnostic and therapeutic procedures in many countries. We explored the impact on…”
Get full text

Sex steroids in relation to cardiac structure and function in men by De Smet, M. A. J., Lapauw, B., De Backer, T.

“…Summary The prevalence of testosterone substitution as well as of androgen deprivation therapy in men is increasing. This review aims to summarise available…”
Get full text

Miconazole buccal gel and risk for systemic bleeding: how certain topical formula can interfere with anticoagulants by De Pauw, A., De Backer, T.

“…The association of miconazole and oral anticoagulants should be carried out with great caution because of potentially serious side effects. This phenomenon is…”
Get full text

Naftidrofuryl for intermittent claudication by De Backer, T L M, Vander Stichele, R, Lehert, P, Van Bortel, L

“…Lifestyle changes and cardiovascular prevention measures are a primary treatment for intermittent claudication (IC). Symptomatic treatment with vasoactive…”
Get more information

Buflomedil for intermittent claudication by de Backer, T L M, Bogaert, M, Vander Stichele, R

“…Intermittent claudication (IC) is pain caused by chronic occlusive arterial disease, that develops in a limb during exercise and is relieved with rest…”
Get more information

Changes in ventriculo-arterial coupling in patients with hypertension and type-2-diabetes after a period of intensified antihypertensive treatment by Soender, T.K, van Bortel, L, de Backer, T

Get full text

Arterial resistance is reduced in patients with type 2 diabetes and resistant hypertension after a median period of 6 months intensified antihypertensive treatment by Soender, T.K, de Backer, T, van Bortel, L

Get full text

Impact of lipid disorders on mortality among Saudi patients with heart failure by Al Qahtani, M., Al Backer, T., Al Anazi, T., Al Johani, N., Binsalih, S., AlGobain, M., Alshammari, H.

“…Dyslipidemia, a known cardiovascular risk factor, is extremely common among Saudis, both adults and children. The impact, however, of dyslipidemia and several…”
Get full text

CARDIOVASCULAR TOXICITY OF CANCER TREATMENT by Combes, M, Rottey, S, De Backer, T

“…Drugs with potential cardiac toxicity are prominent in cancer treatment, not only the old chemotherapeutic agents, but also the newer targeted drugs and…”
Get full text

Perioperative Outcomes of Thoracoscopic Reoperations for Clinical Recurrence of Pulmonary Malignancy by Fabian, Thomas, Van Backer, Justin T., Ata, Ashar

“…The utility of thoracoscopic lung surgery is well established, however, reoperation for pulmonary resections has not been thoroughly studied. We sought to…”
Get full text

P5.13: Changes in Ventriculo-Arterial Coupling in Patients with Hypertension and Type-2-Diabetes after a Period of Intensified Antihypertensive Treatment by Soender, T. K., van Bortel, L., de Backer, T.

“…Objective To examine changes in ventriculo-arterial coupling (VAC) and left ventricular systolic function (LVF SYS ) after a period of intensified…”
Get full text

P1.27: Arterial Resistance is Reduced in Patients with Type 2 Diabetes and Resistant Hypertension after a Median Period of 6 Months Intensified Antihypertensive Treatment by Soender, T. K., de Backer, T., van Bortel, L.

“…Objectives To examine vascular characteristics in patients with type-2-diabetes (T2D) and resistant hypertension (RH) after a median period of 6 months…”
Get full text

Buflomedil for intermittent claudication by de Backer, T L M, Bogaert, M, Vander Stichele, R

“…Intermittent claudication (IC) is pain caused by chronic occlusive arterial disease, that develops in a limb during exercise and is relieved with rest…”
Get more information

Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data by De Backer, T, Vander Stichele, R, Lehert, P, Van Bortel, L

“…Objective To assess the efficacy of naftidrofuryl compared with placebo in treating the symptoms of intermittent claudication.Design Meta-analysis based on…”
Get full text

Propionyl-L-carnitine for intermittent claudication. A cochrane review by De Backer, T, Kamoen, V, Vander Stichele, R, Campens, L, De Bacquer, D, Van Bortel, L

Get full text